Mar 2, 2026 06:37AM
Feb 10, 2026 08:00AM
Feb 2, 2026 08:00AM
Feb 2, 2026 08:00AM
Jan 21, 2026 08:00AM
Dec 29, 2025 08:00AM
Dec 29, 2025 08:00AM neffy® (epinephrine nasal spray) Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions (anaphylaxis)
Nov 10, 2025 06:00AM
Nov 4, 2025 08:00AM
Nov 3, 2025 02:23PM
Nov 3, 2025 02:23PM
Nov 3, 2025 07:45AM
Nov 3, 2025 07:45AM
Oct 8, 2025 08:00AM ARS Pharmaceuticals wins European patent challenge for neffy spray
Oct 8, 2025 08:00AM
Sep 29, 2025 04:06PM
Sep 29, 2025 04:05PM
Sep 19, 2025 08:01AM
Sep 19, 2025 08:00AM
Sep 8, 2025 08:00AM
Aug 13, 2025 07:00AM ARS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Accelerating Growth for neffy® (epinephrine nasal spray)
Jul 18, 2025 09:26AM
Jul 18, 2025 09:25AM
May 14, 2025 07:00AM
May 7, 2025 08:00AM
May 7, 2025 08:00AM
May 2, 2025 08:00AM
Mar 20, 2025 07:00AM ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
Mar 5, 2025 04:11PM
Mar 5, 2025 04:10PM
Mar 5, 2025 04:10PM
Feb 20, 2025 07:02PM
Feb 18, 2025 08:00AM
Jan 21, 2025 08:00AM
Jan 13, 2025 08:00AM ARS Pharmaceuticals Announces Preliminary Fourth Quarter 2024 Financial Results and 2025 Objectives for neffy® (epinephrine nasal spray)
Jan 6, 2025 08:10AM
Jan 6, 2025 08:00AM
Dec 19, 2024 05:25PM
Dec 12, 2024 02:33PM
Dec 12, 2024 02:32PM
Dec 4, 2024 08:00AM
Nov 13, 2024 06:30AM ARS Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates
Nov 11, 2024 07:03AM
Nov 11, 2024 07:00AM
Oct 24, 2024 08:30AM
Oct 24, 2024 08:30AM
Sep 23, 2024 08:12AM
Sep 23, 2024 08:00AM
Sep 9, 2024 04:47PM ARS Pharmaceuticals (SPRY) Submits sNDA to FDA for neffy 1 mg Dose for Pediatric Patients with Type I Allergic Reactions Who Weigh 15 to 30 kg
Sep 9, 2024 04:47PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All